Signal transducer and activator of transcription 4 has been identified as an oncogene in gastric cancer, ovarian cancer, and CRC (Zhou et al., 2014; Cheng et al., 2015; Zhao et al., 2017). This evidence concerns the gene STAT4 and ovarian cancer.